|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Virginia, Charlottesville, VA, USA
2 Department of Internal Medicine, Division of Endocrinology and Metabolism, Mayo Medical and Graduate Schools of Medicine, Rochester, MN, USA
* To whom correspondence should be addressed. E-mail: veldhuis.johannes{at}mayo.edu.
Growth hormone (GH) secretion is vividly pulsatile in all mammalian species studied. In a simplified model, self-renewable GH pulsatility can be reproduced by assuming individual, reversible, time-delayed and threshold-sensitive hypothalamic outflow of GH-releasing hormone (GHRH) and GH release-inhibiting hormone (somatostatin, SRIF). However, this basic concept fails to explicate an array of new experimental observations. Accordingly, here we formulate and implement a novel fourfold ensemble construct, wherein: (i) systemic GH pulses stimulate long-latency, concentration-dependent secretion of periventricular-nuclear SRIF, thereby initially quenching and then releasing multiphasic GH volleys (recurrent every 3 to 3.5 h); (ii) SRIF delivered to the anterior pituitary gland competitively antagonizes exocytotic release, but not synthesis, of GH during intervolley intervals; (iii) arcuate-nucleus GHRH pulses drive the synthesis and accumulation of GH in saturable somatotrope stores; and (iv) a purely intrahypothalamic mechanism sustains high-frequency GH pulses (intervals of 30 to 60 min) within a volley, assuming short-latency reciprocal coupling between (a) GHRH and SRIF neurons (stimulatory direction) and (b) SRIF and GHRH neurons (inhibitory direction). This two-oscillator formulation explicates (but does not prove): (1) the GHRH-sensitizing action of prior somatostatin exposure; (2) a three-site (intrahypothalamic, hypothalamo-pituitary and somatotrope GH store-dependent) mechanism driving rebound-like GH secretion after somatostatin withdrawal in the male; (3) an obligatory role for pituitary GH stores in representing rebound GH release in the female; (4) greater irregularity of SRIF than GH release profiles; and (5) a basis for the paradoxical GH-inhibiting action of centrally delivered GHRH.
This article has been cited by other articles:
![]() |
L. S. Farhy, Z. Du, Q. Zeng, P. P. Veldhuis, M. L. Johnson, K. L. Brayman, and A. L. McCall Amplification of pulsatile glucagon counterregulation by switch-off of {alpha}-cell-suppressing signals in streptozotocin-treated rats Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E575 - E585. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Farhy, C. Y. Bowers, and J. D. Veldhuis Model-projected mechanistic bases for sex differences in growth hormone regulation in humans Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1577 - R1593. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. van Aken, A. M. Pereira, M. Frolich, J. A. Romijn, H. Pijl, J. D. Veldhuis, and F. Roelfsema Growth hormone secretion in primary adrenal Cushing's syndrome is disorderly and inversely correlated with body mass index Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E63 - E70. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Farhy and J. D. Veldhuis Putative GH pulse renewal: periventricular somatostatinergic control of an arcuate-nuclear somatostatin and GH-releasing hormone oscillator Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1030 - R1042. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |